Diane Alter: Biotech ETFs have been the focus of many investors this week after Valeant Pharmaceuticals Intl. Inc. (NYSE:VRX) shares dropped more than 46% last week. 7 Biotech ETFs Getting Crushed By Valeant Stock
Diane Alter: Biotech ETFs have been the focus of many investors this week after Valeant Pharmaceuticals Intl. Inc. (NYSE:VRX) shares dropped more than 46% last week. Changing The Face Of Biotech Investing [iShares NASDAQ Biotechnology Index (ETF), Market Vectors Pharmaceutical ETF]
Lawrence Meyers: If you’re interested in seeking out investments in new biotechnology and pharmaceutical advances that could change the face of health care, then you may want to look at some ETFs that may take advantage of the advance in biosimilars. ETFs To Watch On Solid Pharma Earnings [Market Vectors Pharmaceutical ETF, iShares Dow Jones US Pharm Indx (ETF)]
The healthcare space has emerged relatively unscathed from the biotech meltdown seen early in the year and is clearly outperforming the broad market. This is primarily thanks to strong performances by both biotech and pharma companies ETFs To Watch On Strong Earnings From Pharma Companies [Pfizer Inc., Merck & Co., Inc., Eli Lilly and Co]
The pharma space has been seeing smooth trading thanks to encouraging industry trends such as development of new drugs, the rising wave of mergers and acquisitions, increased need for medical services, expansion into emerging markets This Year’s Hottest Health Care ETFs [Market Vectors Pharmaceutical ETF, Health Care SPDR (ETF)]
David Fabian: As a sector, health care has a lot to offer in terms of fundamental and technical data that supports ongoing innovation and profitability. The aging baby boomer population combined with an increased focus on adorable health insurance is continuing Healthcare ETFs In Focus On Johnson & Johnson Earnings [Gilead Sciences, Inc., AbbVie Inc]
Sweta Killa: The healthcare space has finally emerged from the biotech sell-off and is largely befitting from the rising wave of pharma mergers and acquisitions as well as the current favorable industry trends in both the pharma and biotech corner. Defensive Sectors Are Not Much Help In Market Downturns [Johnson & Johnson, Kellogg Company, The Coca-Cola Company, PepsiCo, Inc.]
Sy Harding: Wall Street’s advice on how to prepare for possible market corrections has always been the same. No matter what happens to the economy people will still have to eat, drink, and take their medicines. So consumer staples, food, beverage, healthcare, December 2013 Distributions for Market Vectors Bank and Brokerage ETF and Market Vectors Pharmaceutical ETF
The Market Vectors ETF Trust announced today the December 2013 distributions per share for the Market Vectors Bank and Brokerage ETF and Market Vectors Pharmaceutical ETF. Quick Investor Guide To Pharmaceutical ETFs
With the year coming to an end, the worst of the patent cliff faced by the pharmaceutical sector in recent times is over. Although genericization will continue, the major patent expiries are over and done with. September 2013 Distributions For Two Market Vectors ETFs
The Market Vectors ETF Trust announced today the September 2013 distributions per share for the Market Vectors Bank and Brokerage ETF and Market Vectors Pharmaceutical ETF. Investor Guide To Four Pharmaceutical ETFs
The pharmaceutical industry has been showing signs of recovery from one of the biggest patent cliffs in recent times. Although genericization will continue, the major patent expiries are over and done with. Focus in the pharma sector is now shifting Market Vectors Distributes Quarterly Dividend for Its Pharmaceutical ETF (PPH)
Market Vectors ETF Trust this week distributed the quarterly dividend for its Pharmaceutical ETF (NYSE Arca: PPH), an exchange-traded fund (ETF) which seeks to track an index comprised of the largest, most liquid global pharmaceutical companies. March 2013 Distributions for Market Vectors Bank and Brokerage ETF and Market Vectors Pharmaceutical ETF
The Market Vectors ETF Trust announced today the March 2013 distributions per share for the Market Vectors Bank and Brokerage ETF and Market Vectors Pharmaceutical ETF. Market Vectors ETFs Offers Five Additional Exchange-Traded Funds to Qualified Investors in Mexico (RTH, OIH, SMH, PPH, BBH)
Market Vectors ETFs, the fifth largest provider of exchange-traded products in the U.S. and the eighth largest provider of ETPs globally, announced today that it has added five NYSE Arca-traded ETFs to the growing list of Market Vectors ETFs currently available to Investors: Beware Of Defensive Stock Advice (XLP, SH, MCD, KO, KFT, PG, ABT, MRK, PPL, DUK)
Sy Harding: With the U.S. economic recovery stumbling again, the euro-zone debt crisis back in the headlines, and ‘Sell in May and Go Away’ on the minds of many investors, Wall Street is beginning to put out advice on how to prepare for a potential market correction.
